Literature DB >> 12559990

Effect of gamma-synuclein overexpression on matrix metalloproteinases in retinoblastoma Y79 cells.

Irina G Surgucheva1, Jeremy M Sivak, M Elizabeth Fini, Robert E Palazzo, Andrei P Surguchov.   

Abstract

gamma-Synuclein is a small cytoplasmic protein implicated in neurodegenerative diseases and cancer. However, the mechanism of its involvement in diseases is not clear. We studied the role of gamma-synuclein in the regulation of matrix metalloproteinases in retinoblastoma cell culture. Matrix metalloproteinases play important roles in the remodeling of extracellular matrix implicated in tumor progression and in the neurodegenerative diseases. Western blot and zymography data demonstrated a moderate elevation of matrix metalloproteinases-2 and significant upregulation of matrix metalloproteinases-9 in stable cell lines overexpressing gamma-synuclein. No effect of gamma-synuclein overexpression on matrix metalloproteinases-1 level or activity was found. Chloramphenicol-acetyltransferase assay demonstrated that overexpression of gamma-synuclein increases the efficiency of the matrix metalloproteinases-9 promoter. This increment of promoter activity may be mediated by the AP-1 binding site(s), since point mutations in one of these sites (Pr18 or Pr19) and elimination of the distal AP-1 site (Pr14) reduced the increment of promoter activity.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12559990     DOI: 10.1016/s0003-9861(02)00664-1

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  21 in total

1.  Synuclein-γ (SNCG) protein expression is associated with poor outcome in endometrial adenocarcinoma.

Authors:  Paulette Mhawech-Fauceglia; Dan Wang; Susanna Syriac; Heidi Godoy; Nefertiti Dupont; Song Liu; Kunle Odunsi
Journal:  Gynecol Oncol       Date:  2011-10-19       Impact factor: 5.482

2.  Expression of gamma-synuclein in colorectal cancer tissues and its role on colorectal cancer cell line HCT116.

Authors:  Qing Ye; Bo Feng; Yuan-Fei Peng; Xue-Hua Chen; Qu Cai; Bei-Qin Yu; Liang-Hui Li; Ming-Yuan Qiu; Bing-Ya Liu; Min-Hua Zheng
Journal:  World J Gastroenterol       Date:  2009-10-28       Impact factor: 5.742

3.  A peptide inhibitor of synuclein-γ reduces neovascularization of human endometriotic lesions.

Authors:  Andrew Kenneth Edwards; Sharanya Ramesh; Vinay Singh; Chandrakant Tayade
Journal:  Mol Hum Reprod       Date:  2014-07-14       Impact factor: 4.025

4.  Whole genome expression analyses of single- and double-knock-out mice implicate partially overlapping functions of alpha- and gamma-synuclein.

Authors:  Melanie Kuhn; Karina Haebig; Michael Bonin; Natalia Ninkina; Vladimir L Buchman; Sven Poths; Olaf Riess
Journal:  Neurogenetics       Date:  2007-02-22       Impact factor: 2.660

5.  Gamma-synuclein: cell-type-specific promoter activity and binding to transcription factors.

Authors:  Irina Surgucheva; Andrei Surguchov
Journal:  J Mol Neurosci       Date:  2008-05-23       Impact factor: 3.444

6.  Effect of gamma-synuclein silencing on apoptotic pathways in retinal ganglion cells.

Authors:  Irina Surgucheva; Valery I Shestopalov; Andrei Surguchov
Journal:  J Biol Chem       Date:  2008-10-20       Impact factor: 5.157

7.  Expression of synuclein gamma indicates poor prognosis of triple-negative breast cancer.

Authors:  Kejin Wu; Shuo Huang; Mingjie Zhu; Yunshu Lu; Jian Chen; Yongkun Wang; Qing Lin; Wei Shen; Shenglai Zhang; Jian Zhu; Y Eric Shi; Ziyi Weng
Journal:  Med Oncol       Date:  2013-05-22       Impact factor: 3.064

8.  The Breast Cancer Susceptibility Gene Product (γ-Synuclein) Alters Cell Behavior through its [corrected] Interaction with Phospholipase Cβ.

Authors:  V Siddartha Yerramilli; Suzanne Scarlata
Journal:  Cell Signal       Date:  2015-10-28       Impact factor: 4.315

9.  γ-Synuclein confers both pro-invasive and doxorubicin-mediated pro-apoptotic properties to the colon adenocarcinoma LS 174T cell line.

Authors:  Kai-Wey Goh; Yee-How Say
Journal:  Tumour Biol       Date:  2015-05-09

10.  PRL-3 promotes the motility, invasion, and metastasis of LoVo colon cancer cells through PRL-3-integrin beta1-ERK1/2 and-MMP2 signaling.

Authors:  Lirong Peng; Xiaofang Xing; Weijun Li; Like Qu; Lin Meng; Shenyi Lian; Beihai Jiang; Jian Wu; Chengchao Shou
Journal:  Mol Cancer       Date:  2009-11-24       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.